Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 93

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1A
Chunk 93
---
(1,654,013)

    CASH,
    BEGINNING OF PERIOD 
     220,467  
     1,874,480 

    CASH,
    END OF PERIOD 
    $92,700  
    $220,467 
  
    SUPPLEMENTAL
    DISCLOSURES OF CASH FLOW INFORMATION 

    Cash
    Paid during the year for: 

    Interest 
    $24,555  
    $20,128 
  
    Income
    Taxes 
    $—  
    $— 

    SUPPLEMENTAL
    DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES 

    Contingent
    Shares issued pursuant to Acquisition Agreement 
    $—  
    $— 
  
    Cancellation
    of restricted stock awards 
    $83  
    $— 
  
    Finance
    agreement entered into in exchange for prepaid assets 
    $1,018,930  
    $906,834 
  
    Conversion
    of note payable for issuance of preferred stock 
    $—  
    $2,000,001 
  
    Note
    payable settled through non-cash exercise of warrants 
    $—  
    $2,000,000 
  
    Debt
    discount related to notes payable 
    $24,954  
    $339,342 
  
    Common
    shares issued upon acquisition 
    $6,058,500  
    $136,001,631 
  
    Contingent
    consideration issued upon acquisition 
    $—  
    $20,557,500 
  
    Common
    shares issued upon settlement of debt 
    $—  
    $9,582,912 
  
    Earn
    out shares issued in settlement of contingent liability 
    $—  
    $11,295,683 
  
    Options
    issued in settlement of debt 
    $—  
    $489,000 
  
    Settlement
    of notes payable 
    $—  
    $418,503 

The accompanying notes are an integral part of these
consolidated financial statements.

F-8

LUNAI BIOWORKS INC. FKA: RENOVARO INC. AND SUBSIDIARIES

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 — ORGANIZATION AND SUMMARY OF